Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine with Statins in Hyperlipidemia
NCT01697735Phase 4Terminated
- Sponsor
- Wenzhou Medical University
- Start
- Sep 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of berberine in hyperlipidemia (2 arms), sponsored by Wenzhou Medical University. Primary endpoint: Change from baseline in combination statins with berberine on lipid level at 8 weeks. Started Sep 2012; status: terminated.
02
Drugs
berberine
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT01697735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697735.